Liver complications in untreated treatment-ineligible versus treated treatment-eligible patients with hepatitis B
Conclusion: Patients never meeting standard AASLD 2018 criteria for antiviral therapy and never treated had twice the risk of developing cirrhosis and/or HCC when compared to eligible and treated patients.
Source: Digestive Diseases - Category: Gastroenterology Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Cirrhosis | Diabetes | Endocrinology | Gastroenterology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology | Women